Clinical Policy: Regorafenib (Stivarga)
Customize your policy alerts
Sign up for Health Net Policy CP PHAR.107 alerts
Get alerted when Policy CP PHAR.107 changes without checking for updates manually.
Monitor payer policy activity
Defines medical necessity criteria, authorization requirements, and approval durations for regorafenib (Stivarga) for FDA-approved and selected off-label oncology indications for Health Net lines of business.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.